Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors
Edward Sisco, Korry Barnes
A series of novel 1,3-oxazole sulfonamides were constructed and screened for their potential to inhibit cancer cell growth. These compounds were evaluated against the full NCI-60 human tumor cell lines; with the majority exhibiting promising overall growth inhibitory properties. They displayed high specificity within the panel of leukemia cell lines vs. all other lines tested. When examined in the dose-response assay GI50 values fell within the low micromolar to nanomolar ranges. 1,3-oxazole sulfonamide 16 displayed the best average growth inhibition, while the 2-chloro-5-methyl (44) and 1-naphthyl (58) analogues proved to be the most potent leukemia inhibitors with mean GI50 values of 48.8 and 44.7 nanomolar respective-ly. In vitro tubulin polymerization experiments revealed that this class of compounds effectively binds to tubulin and induc-es depolymerization of microtubules within cells.
and Barnes, K.
Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors, ACS Medicinal Chemical Letters, [online], https://doi.org/10.1021/acsmedchemlett.1c00219, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=932076
(Accessed October 7, 2022)